Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Survival rates are a way to get an idea of the outlook for children with a certain type of cancer. They can’t tell you for sure if treatment will be successful, but they may help give you a better understanding of how likely this is.
The 5-year survival rate refers to the percentage of children who live at least 5 years after their cancer is diagnosed. Of course, many children live much longer than 5 years (and many are cured).
To get 5-year survival rates, doctors have to look at children who were treated at least 5 years ago. Improvements in treatment since then may result in a better outlook for children now being diagnosed with neuroblastoma.
Survival rates are based on previous outcomes of large numbers of people who had the disease, but they can't predict what will happen in any particular child’s case.
The survival rates below are based on the risk group of the child’s cancer. The risk group, in turn, is based on the stage (extent) of the cancer, as well as other prognostic factors (such as the child’s age). But other factors can also affect a child’s outlook, such as the location of the tumor and how well the cancer responds to treatment. Your child’s doctor can tell you how the numbers below might apply to your child, as they know your situation best.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202–2211.
Pinto NR, Applebaum MA, Volchenboum SL, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015: 30;3008-3017.
Shohet JM, Lowas SR, Nuchtern JG. Treatment and prognosis of neuroblastoma. UpToDate. 2021. Accessed at https://www.uptodate.com/contents/treatment-and-prognosis-of-neuroblastoma on April 7, 2021.
Last Revised: April 28, 2021